IRIS UniCatt

Hohaus, Stefan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.170
EU - Europa 7.344
AS - Asia 6.822
SA - Sud America 1.193
AF - Africa 185
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 11
Totale 24.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.881
SG - Singapore 2.929
DE - Germania 2.296
CN - Cina 1.711
SE - Svezia 1.113
BR - Brasile 975
IT - Italia 853
VN - Vietnam 819
PL - Polonia 721
FR - Francia 571
UA - Ucraina 458
GB - Regno Unito 349
IN - India 282
FI - Finlandia 262
IE - Irlanda 250
ID - Indonesia 176
BD - Bangladesh 174
JP - Giappone 170
CA - Canada 146
RU - Federazione Russa 131
HK - Hong Kong 125
TR - Turchia 91
MX - Messico 84
AR - Argentina 63
IQ - Iraq 56
NL - Olanda 56
ZA - Sudafrica 46
PK - Pakistan 44
AT - Austria 41
ES - Italia 39
CO - Colombia 36
BE - Belgio 35
EC - Ecuador 33
CI - Costa d'Avorio 32
VE - Venezuela 30
AU - Australia 28
KR - Corea 28
CZ - Repubblica Ceca 26
MA - Marocco 26
IR - Iran 24
CH - Svizzera 23
LT - Lituania 23
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
SA - Arabia Saudita 20
KE - Kenya 19
PY - Paraguay 18
IL - Israele 16
MY - Malesia 14
CL - Cile 13
EG - Egitto 13
GR - Grecia 13
RO - Romania 13
TN - Tunisia 13
HN - Honduras 12
JO - Giordania 12
PE - Perù 12
PH - Filippine 12
AZ - Azerbaigian 11
CR - Costa Rica 11
NP - Nepal 10
LV - Lettonia 9
BG - Bulgaria 8
DZ - Algeria 8
ET - Etiopia 8
KZ - Kazakistan 8
JM - Giamaica 7
PT - Portogallo 7
UY - Uruguay 7
AL - Albania 6
DK - Danimarca 6
NO - Norvegia 6
XK - ???statistics.table.value.countryCode.XK??? 6
DO - Repubblica Dominicana 5
GE - Georgia 5
GT - Guatemala 5
HU - Ungheria 5
OM - Oman 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BO - Bolivia 4
BY - Bielorussia 4
CG - Congo 4
EU - Europa 4
HR - Croazia 4
LY - Libia 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
CU - Cuba 3
KW - Kuwait 3
LB - Libano 3
PS - Palestinian Territory 3
SN - Senegal 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
GH - Ghana 2
GY - Guiana 2
Totale 24.714
Salva come PNG Salva come JPEG
Città #
Singapore 1.631
Chandler 1.039
Ashburn 917
San Jose 884
Warsaw 691
Jacksonville 339
Beijing 300
Munich 257
Dublin 241
Los Angeles 238
Ho Chi Minh City 235
Nanjing 223
San Mateo 223
Hanoi 214
New York 208
Houston 205
Ann Arbor 201
Fairfield 200
Woodbridge 195
Dearborn 193
Wilmington 184
Lauterbourg 177
Rome 161
Jakarta 155
Milan 155
Tokyo 144
Hefei 137
Helsinki 128
Cambridge 127
The Dalles 127
Nürnberg 122
Hong Kong 113
Seattle 113
Frankfurt am Main 110
Dallas 109
Chicago 107
Cattolica 98
Boston 88
Bremen 88
Nanchang 85
Moscow 84
Santa Clara 78
Buffalo 77
Redmond 77
São Paulo 75
Lawrence 72
Redwood City 68
Council Bluffs 61
Hyderabad 58
Marseille 58
Princeton 58
St Louis 58
Kunming 54
London 52
Shanghai 48
Lancaster 47
Boardman 46
Da Nang 45
Orem 45
Guangzhou 42
Haiphong 42
Toronto 42
Montreal 41
Izmir 40
Kent 39
Tianjin 39
Norwalk 35
Brooklyn 34
Hangzhou 34
Nuremberg 34
Abidjan 32
Brussels 31
Hebei 31
Mexico City 31
Mountain View 29
Shenyang 29
Zhengzhou 29
Jiaxing 28
Atlanta 27
Rio de Janeiro 27
Seoul 27
Changsha 26
Belo Horizonte 25
Johannesburg 25
Auburn Hills 24
Fremont 24
Leawood 23
Tukwila 23
Amsterdam 22
Baghdad 22
Paris 22
Phoenix 22
Stockholm 22
Chennai 21
Denver 21
Turku 21
University Park 21
Poplar 20
Düsseldorf 19
Nairobi 19
Totale 13.488
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 433
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 366
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 343
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 329
Fanconi anemia gene variants in therapy-related myeloid neoplasms 327
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 302
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 296
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 285
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 282
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 242
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 236
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 235
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 235
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 235
Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 232
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 222
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 203
Why methylation is not a marker predictive of response to hypomethylating agents 202
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 196
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 196
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 193
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 191
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 191
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 190
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 190
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 189
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 188
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 186
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 185
Epigenetic changes in therapy-related MDS/AML 183
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 183
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 181
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 181
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 181
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 176
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 176
Clonal evolution in therapy-related neoplasms 176
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 176
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 175
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 174
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 172
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 170
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 170
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 170
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 170
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 164
Primary multifocal lymphoma of peripheral nervous system: Case report and review of the literature 164
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances 163
Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). 162
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 160
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 160
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 159
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 158
Iron in Hodgkin's lymphoma 158
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 157
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 157
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 157
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 156
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 156
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 156
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 155
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma. 155
PU.1 and CEBPA expression in acute myeloid leukemia. 155
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 155
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 154
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 154
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 152
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 152
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 151
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 151
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 150
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 150
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 149
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 148
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 148
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 146
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 145
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 144
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 144
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 144
Small lymphocytic lymphoma in a patient with Fabry disease 141
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 141
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 141
Outcome of therapy-related myeloid neoplasms treated with azacitidine 139
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 138
Mantle cell lymphoma relapsing at the lymphedematous arm 138
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
Dural MALT Lymphoma Detected by 11C-Methionine PET/CT 137
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 136
Prognostic factors in hodgkin lymphoma 136
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 135
Desensitization to thalidomide in a patient with multiple myeloma 134
Small lymphocytic lymphoma in a patient with Fabry disease 134
Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients 134
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 134
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 133
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 132
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 132
Muscle Recurrence of a Primarily Nodal Follicular Lymphoma Studied by Contrast-Enhanced 18F-FDG PET/CT 132
Totale 18.033
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.293 151 111 20 53 85 36 38 206 64 102 208 219
2022/20232.865 385 396 203 502 180 353 140 230 303 49 84 40
2023/20241.300 56 383 42 66 39 204 52 87 11 39 150 171
2024/20253.402 98 114 247 159 298 119 229 167 456 289 681 545
2025/20269.266 1.174 285 522 872 1.607 548 1.646 567 660 733 379 273
2026/20277 7 0 0 0 0 0 0 0 0 0 0 0
Totale 25.082